| ACGMX | VIVIX | ACGMX / VIVIX | |
| Total Expense Ratio | 0.53 | 0.04 | 1,325% |
| Annual Report Gross Expense Ratio | 0.53 | 0.04 | 1,325% |
| Fund Existence | 21 years | 27 years | - |
| Gain YTD | 11.532 | 11.991 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.19B | 208B | 2% |
| Annual Yield % from dividends | 1.30 | 2.10 | 62% |
| Returns for 1 year | -2.55 | 6.69 | -38% |
| Returns for 3 years | 6.37 | 33.49 | 19% |
| Returns for 5 years | 14.99 | 66.36 | 23% |
| Returns for 10 years | 4.32 | 134.98 | 3% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EIHSX | 14.49 | -0.03 | -0.21% |
| Eaton Vance Worldwide Health Sci I | |||
| SBFIX | 22.98 | -0.24 | -1.03% |
| Federated Hermes Global Allocation IS | |||
| PREQX | 6.35 | -0.07 | -1.09% |
| PACE Global Real Estate Securities P | |||
| SBLYX | 80.24 | -1.50 | -1.84% |
| ClearBridge Large Cap Growth I | |||
| MTCBX | 49.63 | -1.39 | -2.72% |
| MFS Technology B | |||